Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Other Non-Current Assets (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Other Non-Current Assets readings, the most recent being $6.6 million for Q1 2026.

  • Quarterly Other Non-Current Assets fell 21.06% to $6.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Mar 2026, down 21.06% year-over-year, with the annual reading at $7.2 million for FY2025, 19.19% down from the prior year.
  • Other Non-Current Assets hit $6.6 million in Q1 2026 for Oric Pharmaceuticals, down from $7.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $12.4 million in Q2 2022 and bottomed at $6.6 million in Q1 2026.
  • Average Other Non-Current Assets over 5 years is $9.6 million, with a median of $9.6 million recorded in 2024.
  • The largest annual shift saw Other Non-Current Assets surged 755.63% in 2022 before it decreased 25.35% in 2025.
  • Oric Pharmaceuticals' Other Non-Current Assets stood at $11.5 million in 2022, then fell by 15.81% to $9.7 million in 2023, then fell by 7.51% to $9.0 million in 2024, then decreased by 19.19% to $7.2 million in 2025, then dropped by 8.89% to $6.6 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Other Non-Current Assets are $6.6 million (Q1 2026), $7.2 million (Q4 2025), and $7.1 million (Q3 2025).